Medical history, lifestyle, family history, and occupational risk factors for Diffuse Large B-cell Lymphoma: The interLymph non-Hodgkin lymphoma subtypes project

Journal of the National Cancer Institute - Monographs

Volumn , Issue 48, 2014, Pages 15-25

  Cerhan, James R ^a   Kricker, Anne ^b   Paltiel, Ora ^c   Flowers, Christopher R ^d   Wang, Sophia S ^e   Monnereau, Alain ^f,g,h   Blair, Aaron ⁱ   Maso, Luigino Dal ^j   Kane, Eleanor V ^k   Nieters, Alexandra ^l   Foran, James M ^m   Miligi, Lucia ⁿ   Clavel, Jacqueline ^f,g   Bernstein, Leslie ^e   Rothman, Nathaniel ⁱ   Slager, Susan L ^a   Sampson, Joshua N ⁱ   Morton, Lindsay M ⁱ   Skibola, Christine F ^o  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d EMORY UNIVERSITY   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h INSTITUT BERGONIÉ   (France)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^k UNIVERSITY OF YORK   (United Kingdom)

^l UNIVERSITY OF FREIBURG   (Germany)

^m MAYO CLINIC   (United States)

ⁿ Cancer Prevention and Research Institute (ISPO)   (Italy)

^o UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HAIR DYE; ORAL CONTRACEPTIVE AGENT;

AGRICULTURAL WORKER; ALCOHOL CONSUMPTION; ARTICLE; ATOPY; AUTOIMMUNE DISEASE; BLOOD TRANSFUSION; BODY MASS; CANCER RISK; FAMILY HISTORY; GENETIC HETEROGENEITY; HAIRDRESSER; HORMONE SUBSTITUTION; HUMAN; INFLAMMATORY BOWEL DISEASE; LARGE CELL LYMPHOMA; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MATERIALS HANDLING; MEDICAL HISTORY; NONHODGKIN LYMPHOMA; NONMEDICAL OCCUPATIONS; OCCUPATIONAL HAZARD; ORAL CONTRACEPTIVE USE; RISK ASSESSMENT; SEAMSTRESS; SEX RATIO; SMOKING; SOCIAL STATUS; SUN EXPOSURE; ADULT; AGED; AUSTRALIA; CASE CONTROL STUDY; COMORBIDITY; EUROPE; FEMALE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; META ANALYSIS; MIDDLE AGED; NORTH AMERICA; OCCUPATIONAL EXPOSURE; ODDS RATIO; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CASE-CONTROL STUDIES; COMORBIDITY; EUROPE; FEMALE; HUMANS; LIFE STYLE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NORTH AMERICA; OCCUPATIONAL EXPOSURE; ODDS RATIO; RISK FACTORS; YOUNG ADULT;

EID: 84906841542     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgu010     Document Type: Article

References (52)

1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute. Bethesda, MD, http://seer.cancer. gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER website April 2013. Accessed 10 May 2013.
2. Sant M, Allemani C, Tereanu C, et al.; HAEMACARE Working Group. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724-3734.
3. Flowers CR, Sinha R, Vose JM. Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin. 2010;60(6):393-408.
4. Shenoy PJ, Malik N, Nooka A, et al. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer. 2011;117(11):2530-2540.
5. Møller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation- a population-based study of 1575 cases. Br J Haematol. 2004;124(2):151-159.
6. Gundrum JD, Mathiason MA, Moore DB, Go RS. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol. 2009;27(31):5227-5232.
7. Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol. 1999;43(3):199-201.
8. Zinzani PL, Piccaluga PP. Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies. Curr Oncol Rep. 2011;13(5):407-415.
9. Stanojevic GZ, Nestorovic MD, Brankovic BR, Stojanovic MP, Jovanovic MM, Radojkovic MD. Primary colorectal lymphoma: an overview. World J Gastrointest Oncol. 2011;3(1):14-18.
10. Markova A, Weinstock MA. Trends in cutaneous lymphoma epidemiology. Clin Lymphoma Myeloma Leuk. 2010;10(suppl 2):S63-S66.
11. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503-511.
12. Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Cancer Epidemiol Biomarkers Prev. 2005;14(4):925-933.
13. Wang SS, Slager SL, Brennan P, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;109(8):3479-3488.
14. de Sanjose S, Benavente Y, Vajdic CM, et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 2008;6(4):451-458.
15. Kricker A, Armstrong BK, Hughes AM, et al.; Interlymph Consortium. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer. 2008;122(1):144-154.
16. Ekström Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111(8):4029-4038.
17. Willett EV, Morton LM, Hartge P, et al.; Interlymph Consortium. Non- Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer. 2008;122(9):2062-2070.
18. Vajdic CM, Falster MO, de Sanjose S, et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res. 2009;69(16):6482-6489.
19. Kane EV, Bernstein L, Bracci PM, et al.; InterLymph Consortium. Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies. Ann Oncol. 2013;24(2):433-441.
20. Kane EV, Roman E, Becker N, et al.; InterLymph Consortium. Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph casecontrol studies. Ann Oncol. 2012;23(9):2362-2374.
21. Zhang Y, Sanjose SD, Bracci PM, et al. Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol. 2008;167(11):1321-1331.
22. Morton LM, Sampson JN, Cerhan JR, et al. Rationale and design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014(48):1-14.
23. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics, Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
24. Swerdlow S, Campo E, Harris N, et al., eds World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
25. Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110(2):695-708.
26. Turner JJ, Morton LM, Linet MS, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 2010;116(20):e90-e98.
27. Johnson CH, Adamo M, Dickie L, et al. 2012 Hematopoietic Manual, Version 2.2. Bethesda, MD: National Cancer Institute, 20892-8316.
28. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
29. Bertrand KA, Giovannucci E, Zhang SM, Laden F, Rosner B, Birmann BM. A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma. Cancer Prev Res (Phila). 2013;6(8):864-873.
30. Maskarinec G, Erber E, Gill J, Cozen W, Kolonel LN. Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2008;17(1):196-203.
31. Cerhan JR, Janney CA, Vachon CM, et al. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol. 2002;156(6):527-535.
32. Patel AV, Diver WR, Teras LR, Birmann BM, Gapstur SM. Body mass index, height and risk of lymphoid neoplasms in a large United States cohort. Leuk Lymphoma. 2013;54(6):1221-1227.
33. Pylypchuk RD, Schouten LJ, Goldbohm RA, Schouten HC, van den Brandt PA. Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. Am J Epidemiol. 2009;170(3):297-307.
34. Troy JD, Hartge P, Weissfeld JL, et al. Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol. 2010;171(12):1270-1281.
35. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med. 2010;61:301-316.
36. Purdue MP, Freedman DM, Gapstur SM, et al. Circulating 25-hydroxyvitamin D and risk of non-Hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):58-69.
37. Norval M, Halliday GM. The consequences of UV-induced immunosuppression for human health. Photochem Photobiol. 2011;87(5):965-977.
38. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol. 2011;11(9):584-596.
39. Gorman S, Scott NM, Tan DH, et al. Acute erythemal ultraviolet radiation causes systemic immunosuppression in the absence of increased 25-hydroxyvitamin D3 levels in male mice. PLoS One. 2012;7(9):e46006.
40. Norval M, McLoone P, Lesiak A, Narbutt J. The effect of chronic ultraviolet radiation on the human immune system. Photochem Photobiol. 2008;84(1):19-28.
41. Schwarz T. 25 years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cells. Photochem Photobiol. 2008;84(1):10-18.
42. Castillo JJ, Dalia S, Pascual SK. Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood. 2010;116(16):2897-2907.
43. Becker N, Berger J, Bolm-Audorff U. Asbestos exposure and malignant lymphomas-a review of the epidemiological literature. Int Arch Occup Environ Health. 2001;74(7):459-469.
44. Blair A, Linos A, Stewart PA, et al. Comments on occupational and environmental factors in the origin of non-Hodgkin's lymphoma. Cancer Res. 1992;52(suppl 19):5501s-5502s.
45. Boffetta P, de Vocht F. Occupation and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16(3):369-372.
46. Pearce N, McLean D. Agricultural exposures and non-Hodgkin's lymphoma. Scand J Work Environ Health. 2005;31(suppl 1):18-25; discussion 15-17.
47. Neasham D, Sifi A, Nielsen KR, et al. Occupation and risk of lymphoma: a multicentre prospective cohort study (EPIC). Occup Environ Med. 2011;68(1):77-81.
48. Kennedy SM, Koehoorn M. Exposure assessment in epidemiology: does gender matter? Am J Ind Med. 2003;44(6):576-583.
49. Eng A, 't Mannetje A, McLean D, Ellison-Loschmann L, Cheng S, Pearce N. Gender differences in occupational exposure patterns. Occup Environ Med. 2011;68(12):888-894.
50. Schiff D, Suman VJ, Yang P, Rocca WA, O'Neill BP. Risk factors for primary central nervous system lymphoma: a case-control study. Cancer. 1998;82(5):975-982.
51. Howell JM, Auer-Grzesiak I, Zhang J, Andrews CN, Stewart D, Urbanski SJ. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population. Can J Gastroenterol. 2012;26(7):452-456.
52. Andrews CN, John Gill M, Urbanski SJ, Stewart D, Perini R, Beck P. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study. Am J Gastroenterol. 2008;103(7):1762-1769.